Study Title and Description
The Cairo kidney center protocol for rapamycin-based sequential immunosuppression in kidney transplant recipients: 2-year outcomes.
Key Questions Addressed
|3||In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?|
Primary Publication Information
|Title||The Cairo kidney center protocol for rapamycin-based sequential immunosuppression in kidney transplant recipients: 2-year outcomes.|
|Author||Barsoum RS., Morsey AA., Iskander IR., Morgan MM., Fayad TM., Atalla NT., Wafik H., Grace RA., Adel N., Khalil SS.|
|Country||The Cairo Kidney Center, Cairo, Egypt. Rashad.firstname.lastname@example.org|
Pubmed ID: 18194116
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Comparative Effectiveness of Regimens
Results & Comparisons
No Results found.